The first all-new 2017 Subaru Impreza rolled off the assembly line at Subaru of Indiana Automotive, Inc. (SIA), officially launching the first-ever American-built Impreza from the automaker. The Impreza had historically been produced only in Japan. The start of Impreza production marks the culmination of more than three years of preparation and highlights the consistent growth in Subaru demand in the United States (U.S.). The positive economic impact of that growth is clear in the investment Subaru made to increase SIA’s production capacity and prepare for Impreza production. SIA invested $1.3 billion over the past four years, and hired an additional 1,400 associates in the past year.
“In a time when some manufacturers are moving work out of the United States, we’re proud to be bringing Subaru Impreza production to the heartland of America,” said Tom Easterday, Senior Executive Vice President of SIA. “The move has allowed us to create hundreds of new jobs not only at SIA, but also at our suppliers in Indiana and across the country.”
The all-new 2017 Subaru Impreza is the first vehicle built using the new Subaru Global Platform architecture that is designed to enhance safety, comfort, agility and driving pleasure. Available in sedan and 5-door models, the 2017 Impreza is equipped with new driver assist technology, multimedia features and standard Symmetrical All-Wheel Drive. The new Impreza will be available in base, Premium, Sport and Limited trim lines starting in late 2016.
To view the multimedia release go to:
http://www.multivu.com/players/English/7673252-subaru-impreza-first-2017-american-made/
Through thousands of hours meeting with women from Dallas to Taipei, Sao Paulo to Paris, Neutrogena® uncovered a universal truth – women are stepping back to examine what’s possible in their lives so they can pursue their dreams. Always on a mission to create, innovate, and rethink what’s possible in skincare, Neutrogena® identified this shared value and was inspired to launch its first-ever global campaign: “Neutrogena. See What’s Possible.™”
“Neutrogena® started as a dream, and through scientific discovery, creative thinking and the resilience to defy expectations without any compromises, a brand was born,” said Alicia Sontag, President, Beauty Care, Johnson & Johnson Consumer Inc. “We support women around the world and are proud to help them put their best face forward as they pursue their own dreams – big or small.”
The “Neutrogena. See What’s Possible™” campaign will debut with a commercial voiced by Brand Ambassador and creative consultant Kerry Washington which features real women following their passions. The empowering video brings to life the brand’s point of view on beauty – what really makes a woman beautiful is the ability to look in the mirror and know that anything is possible. In addition, educational and inspiring digital content designed to encourage her along her journey will be leveraged through social platforms in over 27 countries around the world, making this the largest digitally-driven campaign the brand has ever executed.
To view the multimedia release go to:
http://www.multivu.com/players/English/7770451-neutrogena-see-what-s-possible/
Netflix, Inc. (Nasdaq: NFLX) has unveiled revealing, new information that confirms a sneaking suspicion— more than half (51%) of couples are likely to “cheat”1—but don’t start grilling your significant other or giving them the evil eye just yet.
A recent survey conducted by Harris Interactive on behalf of Netflix2 revealed 51% of those in a relationship would “cheat” on their spouse/partner/significant other by streaming a TV program(s) they agreed to watch together before their partner had a chance to watch it. More specifically, more than 28 million3 U.S. adults (12%) confessed they had already cheated and 10% admitted they had been “cheated on4.” It seems as though sometimes that next episode of your favorite series is just too tempting to wait for your partner. Sneaking around with that addictive little show may seem like a minor form of infidelity—but don’t be surprised if it leads to a few slamming doors and a bit of the silent treatment.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61735-netflix-survey-more-than-half-of-couples-consider-stream-cheating
Nancy Lieberman, basketball hall of famer, coach and mom, has teamed up with Sanofi’s consumer healthcare division Chattem Inc. to introduce a new, more effective player on the over-the-counter (OTC) allergy medication roster, Nasacort Allergy 24HR Nasal Spray. Now available in stores nationwide, Nasacort Allergy 24HR is different than other currently available OTC allergy medications. It puts the “Full ‘Cort Press” on the full range of nasal allergy symptoms for 24 hours with a once daily dose. Nasacort Allergy 24HR is the first and only medicine in its class to be available at full prescription strength without the need for a prescription.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/7122351-basketball-hall-of-famer-nancy-lieberman-nasacort-allergy-24hr
The Light of Life Foundation, ThyCa: Thyroid Cancer Survivors’ Association, Inc., and Eisai Inc. today announced the launch of Myths and Truths About Thyroid Cancer, an interactive, educational campaign designed to help dispel the myth that thyroid cancer is a “good cancer.” Because most thyroid cancers can be successfully treated, many are told if you are going to get cancer, thyroid cancer is the one to have, which has led to this misperception. However, whether successfully treated or not, the truth is all cancers can have a significant impact on a person’s life, beginning with the shock and distress of hearing the word “cancer” at diagnosis. In honor of Thyroid Cancer Awareness Month and the tens of thousands who receive a thyroid cancer diagnosis each year, Myths and Truths About Thyroid Cancer illustrates the life-changing realities of this disease.
“As a thyroid cancer survivor, I urge people to stop referring to thyroid cancer as the ‘good cancer,’ as I believe it downplays patients’ experiences,” said Joan Shey, founder of the Light of Life Foundation. “I hear time and time again from patients how difficult their diagnosis and treatment were and that their scars are more than skin deep. My hope is that this campaign can educate about the many types of thyroid cancer and change the thyroid cancer conversation.”
“Being part of a community of survivors is very important for people coping with thyroid cancer,” said Gary Bloom, thyroid cancer survivor and co-founder and executive director of ThyCa: Thyroid Cancer Survivors’ Association. “ThyCa takes this to heart, which is why we are proud to provide support and resources to the thyroid cancer community. We also know more needs to be done to elevate awareness of thyroid cancer and what patients need in terms of support for the rest of our lives.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7595951-eisai-thyroid-cancer-myths/
Boehringer Ingelheim Pharmaceuticals, Inc. and CancerCare® today announced the launch of My Cancer Circle™ (www.MyCancerCircle.net), a free, private, customizable online tool that enables caregivers of people facing cancer to organize and coordinate a circle of family members and friends to provide practical and emotional support. MyCancerCircle.net will provide caregivers of people facing cancer a simple, effective answer to a question they are asked constantly, “What can we do to help?”
To view Multimedia News Release, go to http://www.multivu.com/mnr/56339-boehringer-ingelheim-cancercare-my-cancer-circle-online-tool-caregivers
Munchkin, Inc., designer and manufacturer of clever infant and toddler products, today announced that its new Fresh Baby Food System, helping parents make healthy baby food at home, is now available at retailers nationwide. The four new products in the system offer parents a way to introduce healthy feeding habits to their children at a young age via a simple, three-step process.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59935-munchkin-homemade-fresh-baby-food-system
Based on its recent analysis of the mobile collaboration solutions market, Frost & Sullivan recognizes Damaka, Inc. with the 2010 North American Frost & Sullivan Award for New Product Innovation of the Year for the development of the Amadeo™ platform. Damaka offers secured and viable communication applications across different mobile devices and network infrastructure. It promises a next generation mobile unified communications and collaboration (UCC) service to equip mobile employees with a higher grade of flexibility and efficiency.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/frostsullivan/51016/
Starting November 1st and continuing through November 10th, 2010, Mitsubishi Motors North America, Inc., (MMNA), will host Mitsubishi Live Drive, the World\'s First Online Test Drive of an actual vehicle utilizing interactive remote control of the company’s latest automotive creation, the all-new 2011 Outlander Sport.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/mitsubishi/46514/
Miral and SeaWorld Entertainment, Inc. (NYSE:SEAS) (“SeaWorld”) today announced their partnership to develop SeaWorld Abu Dhabi, a first-of-its-kind marine life themed park on Yas Island. This next generation SeaWorld Abu Dhabi will also include the United Arab Emirates’ (“UAE”) first dedicated marine life research, rescue, rehabilitation and return center with world-class facilities and resources for the care and conservation of local marine life. SeaWorld Abu Dhabi will be the first new SeaWorld without orcas, and will integrate up-close animal experiences, mega attractions and a world class aquarium, bringing the latest technology in visitor engagement.
The partnership brings together Miral’s expertise in developing Yas Island’s portfolio of destinations with SeaWorld’s 50-plus years of theme park, veterinary medicine, marine science and zoological practice and experience.
To view the multimedia release go to:
http://www.multivu.com/players/uk/8002251-miral-announces-seaworld-yas-island/
Epson America, Inc. today announced that Millstone Medical Outsourcing, a Massachusetts-based provider of medical packaging outsourcing solutions, has selected the Epson ColorWorks® C7500G inkjet label printer to create high-quality color and black-and-white packaging labels for its growing roster of orthopedic and spine customers. As a leading provider of packaging and distribution services, including advanced inspection and validation of medical and clean room device packaging and re-packaging, Millstone Medical Outsourcing required a high-quality label printing solution to address the varying demands of its customers, and the Epson ColorWorks C7500G provided a flexible and easy-to-use option to meet their needs.
“Our customers demand durable, high-quality label and packaging solutions with sometimes very specific details such as barcodes, graphics and meticulous logos – expectations that laser printers, and even legacy two-step inkjet color printing solutions, just couldn’t meet,” said Michael Morrissette, program manager, Millstone Medical Outsourcing. “Using the Epson ColorWorks solution to print on-demand, full color labels has allowed us to better manage our expenses and keep up with the ever-changing medical packaging market. The Epson printer is a product that we can rely on to get the job done for our clients.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7820752-epson-millstone-medical-case-study/
